Mamasalagat, Perly D.

HRN: 21-17-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2023
CEFUROXIME 1.5GM (VIAL)
06/17/2023
06/19/2023
IV
1.5gms
Q8hrs X 6 Doses
S/P Primary LSTCS With IUD Insertion
Waiting Final Action 
06/22/2023
CEFUROXIME 500MG (TAB)
06/22/2023
06/29/2023
PO
500mg
BID X 7 Days
S/P LTCS; Leukocytosis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: